Cyclooxygenase inhibitors use is associa
β
Zhang, S; Zhang, X-Q; Ding, X-W; Yang, R-K; Huang, S-L; Kastelein, F; Bruno, M;
π
Article
π
2014
π
Nature Publishing Group
π
English
β 829 KB
## Background: Esophageal adenocarcinoma (EAC) has high mortality and is increasing in incidence. Barrett's esophagus (BE) increases the risk for EAC. Studies have reported inconsistent findings on the association between use of cyclooxygenase (COX) inhibitors and the risk of neoplastic progression